Supplementary Figure S1 from Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non–small Cell Lung Cancer: TORG1937 (DATE Study)
Authors:
- Shinji NakamichiSNShinji Nakamichi
- Kaoru KubotaKKKaoru Kubota
- Toshihiro MisumiTMToshihiro Misumi
- Tetsuro KondoTKTetsuro Kondo
- Shuji MurakamiSMShuji Murakami
- Yoshimasa ShiraishiYSYoshimasa Shiraishi
- Hisao ImaiHIHisao Imai
- Daijiro HaradaDHDaijiro Harada
- Kazutoshi IsobeKIKazutoshi Isobe
- Hidetoshi ItaniHIHidetoshi Itani
- Saori TakataSTSaori Takata
- Hiroshi WakuiHWHiroshi Wakui
Open Access
- 15 March 2024
- other
- Published by American Association for Cancer Research (AACR)